|
See related Januvia tab information |
|
|
|
Manufacturer |
MSD |
|
Distributor |
Hong Kong: DKSH/Macau: Four Star |
|
Contents |
Sitagliptin |
|
Indications |
Monotherapy as adjunct to diet & exercise to improve glycemic control in patients w/ type 2 DM.
Click to view Januvia detailed prescribing infomation |
|
Dosage |
100 mg once daily.
Click to view Januvia detailed prescribing infomation |
|
Overdosage |
View Januvia overdosage for action to be taken in the event of an overdose. |
|
Administration |
May be taken with or without food |
|
Contraindications |
[Click for Januvia detailed prescribing infomation] |
|
Special Precautions |
Type 1 DM, diabetic ketoacidosis; patients w/ renal insufficiency. Pregnancy & lactation. Childn <18 yr.
Click to view Januvia detailed prescribing infomation |
|
Adverse Drug Reactions |
Flu, headache, diarrhea, indigestion, flatulence, vomiting, constipation; hypoglycemia, upper resp infection, nausea, cough, skin fungal infection; swellings of hands, legs, face, tongue & throat; rash, hives. Pancreatitis.
View ADR Monitoring Form |
|
Side Effects |
View Januvia side effects |
|
Drug Interactions |
[Click for Januvia detailed prescribing infomation]
View more drug interactions with Januvia |
|
Pregnancy Category (US FDA) |
Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are no controlled studies in pregnant women or animal-reproduction studies have shown an adverse effect (other than a decrease in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is no evidence of a risk in later trimesters). |
|
Storage |
View Januvia storage conditions for details to ensure optimal shelf-life. |
|
Description |
View Januvia description for details of the chemical structure and excipients (inactive components). |
|
Mechanism of Action |
View Januvia mechanism of action for pharmacodynamics and pharmacokinetics details. |
|
